A multicenter double-blind randomized study was carried out to compare the effect of timolol (10 mg twice daily) with that of placebo in patients surviving acute myocardial infarction. Treatment was started seven to 28 days after infarction in 1884 patients (945 taking timolol, and 939 placebo), who represented 52 per cent of those evaluated for entry; the patients were followed for 12 to 33 months (mean, 17). There were 152 deaths in the placebo group and 98 in the timolol group. When deaths that occurred during treatment or within 28 days of withdrawal were considered, the cumulated sudden-death rate over 33 months was 13.9 per cent in the placebo group and 7.7 per cent in the timolol group--a reduction of 44.6 per cent (P = 0.0001). The cumulated reinfarction rate was 20.1 per cent in the placebo group and 14.4 per cent in the timolol group (P = 0.0006). We conclude that long-term treatment with timolol in patients surviving acute myocardial infarction reduces mortality and the rate of reinfarction.
This article has been cited by other articles:
Au, D. H
(2008). Use of {beta} blockers in patients with COPD. Thorax
63: 296-298
[Full Text]
Sipahi, I., Nissen, S. E.
(2008). {beta}-Blockers and Progression of Coronary Atherosclerosis. ANN INTERN MED
148: 404-405
[Full Text]
Cucherat, M.
(2007). Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J
28: 3012-3019
[Abstract][Full Text]
Albert, N. M.
(2007). Switching to Once-Daily Evidence-Based -Blockers in Patients With Systolic Heart Failure or Left Ventricular Dysfunction After Myocardial Infarction. Crit Care Nurse
27: 62-72
[Full Text]
Hjalmarson, A.
(2007). Heart rate: an independent risk factor in cardiovascular disease. Eur Heart J Suppl
9: F3-F7
[Abstract][Full Text]
Sipahi, I., Tuzcu, E. M., Wolski, K. E., Nicholls, S. J., Schoenhagen, P., Hu, B., Balog, C., Shishehbor, M., Magyar, W. A., Crowe, T. D., Kapadia, S., Nissen, S. E.
(2007). {beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials. ANN INTERN MED
147: 10-18
[Abstract][Full Text]
Alexander, K. P., Newby, L. K., Armstrong, P. W., Cannon, C. P., Gibler, W. B., Rich, M. W., Van de Werf, F., White, H. D., Weaver, W. D., Naylor, M. D., Gore, J. M., Krumholz, H. M., Ohman, E. M.
(2007). Acute Coronary Care in the Elderly, Part II: ST-Segment-Elevation Myocardial Infarction: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology: In Collaboration With the Society of Geriatric Cardiology. Circulation
115: 2570-2589
[Abstract][Full Text]
Anderson, J. R., Nagajothi, N., Velazquez-Cecena, J.-L. E., Khosla, S., Wong, B., Erdogan, O., De Luca, L., Tomai, F., Chua, D., Lo, A., Kuo, I. F., Hochman, J. S., Forman, S., Reynolds, H. R., the Occluded Artery Trial Investigators, , Hillis, L. D., Lange, R. A.
(2007). Persistent Coronary Occlusion after Myocardial Infarction. NEJM
356: 1681-1684
[Full Text]
Goyal, A., Alexander, J. H., Hafley, G. E., Graham, S. H., Mehta, R. H., Mack, M. J., Wolf, R. K., Cohn, L. H., Kouchoukos, N. T., Harrington, R. A., Gennevois, D., Gibson, C. M., Califf, R. M., Ferguson, T. B. Jr, Peterson, E. D., PREVENT IV Investigators,
(2007). Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery. Ann. Thorac. Surg.
83: 993-1001
[Abstract][Full Text]
Werner, R. M., Bradlow, E. T.
(2006). Relationship Between Medicare's Hospital Compare Performance Measures and Mortality Rates. JAMA
296: 2694-2702
[Abstract][Full Text]
Hays, A. G., Sacco, R. L., Rundek, T., Sciacca, R. R., Jin, Z., Liu, R., Homma, S., Di Tullio, M. R.
(2006). Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population. Stroke
37: 1715-1719
[Abstract][Full Text]
Laowattana, S., Zeger, S. L., Lima, J.A.C., Goodman, S. N., Wittstein, I. S., Oppenheimer, S. M.
(2006). Left insular stroke is associated with adverse cardiac outcome. Neurology
66: 477-483
[Abstract][Full Text]
Lopez-Sendon, J., Swedberg, K., Torp-Pedersen, C., Tendera, M., Maggioni, A. P., for the Task Force on Beta-Blockers of the Europea,
(2006). Is the level of evidence for the use of beta-blockers in acute myocardial infarction satisfactory enough?: reply. Eur Heart J
27: 119-119
[Full Text]
Pratt, C. M.
(2005). Three decades of clinical trials with beta-blockers: The contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias. J Am Coll Cardiol
45: 531-532
[Full Text]
Gluckman, T. J., Sachdev, M., Schulman, S. P., Blumenthal, R. S.
(2005). A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA
293: 349-357
[Abstract][Full Text]
Okrainec, K., Platt, R., Pilote, L., Eisenberg, M. J.
(2005). Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials. J Am Coll Cardiol
45: 177-184
[Abstract][Full Text]
Task Force Members, , Lopez-Sendo, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Pedersen, C. T., ESC Committee for Practice Guidelines, , Priori, S. G., Alonso Garcia, M. A., Blanc, J.-J., Budaj, A., Cowie, M., Dean, V., Deckers, J., Fernandez Burgos, E., Lekakis, J., Lindahl, B., Mazzotta, G., McGregor, K., Morais, J., Oto, A., Smiseth, O. A., Document Reviewers, , Alonso Garcia, M. A., Ardissino, D., Avendano, C., Lundqvist, C. B., ment, D. C., Drexler, H., Ferrari, R., Fox, K. A., Julian, D., Kearney, P., Klein, W., ber, L. K., Mancia, G., Nieminen, M., Ruzyllo, W., Simoons, M., Thygesen, K., Tognoni, G., Tritto, I., Wallentin, L.
(2004). Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J
25: 1341-1362
[Full Text]
Gluckman, T. J., Baranowski, B., Ashen, M. D., Henrikson, C. A., McAllister, M., Braunstein, J. B., Blumenthal, R. S.
(2004). A Practical and Evidence-Based Approach to Cardiovascular Disease Risk Reduction. Arch Intern Med
164: 1490-1500
[Abstract][Full Text]
Hueb, W., Soares, P. R., Gersh, B. J., Cesar, L. A. M., Luz, P. L., Puig, L. B., Martinez, E. M., Oliveira, S. A., Ramires, J. A. F.
(2004). The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: One-year results. J Am Coll Cardiol
43: 1743-1751
[Abstract][Full Text]
Bradley, E H, Holmboe, E S, Mattera, J A, Roumanis, S A, Radford, M J, Krumholz, H M
(2004). Data feedback efforts in quality improvement: lessons learned from US hospitals. Qual Saf Health Care
13: 26-31
[Abstract][Full Text]
Everly, M. J, Heaton, P. C, Cluxton, R. J Jr
(2004). {beta}-Blocker Underuse in Secondary Prevention of Myocardial Infarction. The Annals of Pharmacotherapy
38: 286-293
[Abstract][Full Text]
Dornbrook-Lavender, K. A, Roth, M. T, Pieper, J. A
(2003). Secondary Prevention of Coronary Heart Disease in the Elderly. The Annals of Pharmacotherapy
37: 1867-1876
[Abstract][Full Text]
Silvet, H., Spencer, F., Yarzebski, J., Lessard, D., Gore, J. M., Goldberg, R. J.
(2003). Communitywide Trends in the Use and Outcomes Associated With {beta}-Blockers in Patients With Acute Myocardial Infarction: The Worcester Heart Attack Study. Arch Intern Med
163: 2175-2183
[Abstract][Full Text]
van der Elst, M. E, Buurma, H., Bouvy, M. L, de Boer, A.
(2003). Drug Therapy for Prevention of Recurrent Myocardial Infarction. The Annals of Pharmacotherapy
37: 1465-1477
[Abstract][Full Text]
Devereux, R. B., Dahlof, B., Kjeldsen, S. E., Julius, S., Aurup, P., Beevers, G., Edelman, J. M., de Faire, U., Fyhrquist, F., Sigrid Helle Berg, , Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S., Snapinn, S., Wedel, H., for the LIFE Study Group*,
(2003). Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial. ANN INTERN MED
139: 169-177
[Abstract][Full Text]
Burwen, D. R., Galusha, D. H., Lewis, J. M., Bedinger, M. R., Radford, M. J., Krumholz, H. M., Foody, J. M.
(2003). National and State Trends in Quality of Care for Acute Myocardial Infarction Between 1994-1995 and 1998-1999: The Medicare Health Care Quality Improvement Program. Arch Intern Med
163: 1430-1439
[Abstract][Full Text]
Pfeffer, M.A.
(2003). The intersection between acute coronary syndrome and heart failure. Eur Heart J Suppl
5: C19-C23
[Abstract]
Abildstrom, S Z, Rask-Madsen, C, Ottesen, M M, Andersen, P K, Rosthoj, S, Torp-Pedersen, C, Kober, L
(2002). Impact of age and sex on sudden cardiovascular death following myocardial infarction. Heart
88: 573-578
[Abstract][Full Text]
Ellison, K. E., Hafley, G. E., Hickey, K., Kellen, J., Coromilas, J., Stein, K. M., Lee, K. L., Buxton, A. E., for the MUSTT Investigators,
(2002). Effect of {beta}-Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT). Circulation
106: 2694-2699
[Abstract][Full Text]
Geraci, S. A., Haan, C. K.
(2002). Effect of beta blockers after coronary artery bypass in postinfarct patients: what can we learn from available literature?. Ann. Thorac. Surg.
74: 1727-1732
[Abstract][Full Text]
Wright, R. S., Reeder, G. S., Herzog, C. A., Albright, R. C., Williams, B. A., Dvorak, D. L., Miller, W. L., Murphy, J. G., Kopecky, S. L., Jaffe, A. S.
(2002). Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination. ANN INTERN MED
137: 563-570
[Abstract][Full Text]
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., Arnesen, H.
(2002). Warfarin, Aspirin, or Both after Myocardial Infarction. NEJM
347: 969-974
[Abstract][Full Text]
Kjeldsen, S. E., Dahlof, B., Devereux, R. B., Julius, S., Aurup, P., Edelman, J., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristianson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S., Snapinn, S., Wedel, H., for the LIFE Study Group,
(2002). Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy: A Losartan Intervention For Endpoint Reduction (LIFE) Substudy. JAMA
288: 1491-1498
[Abstract][Full Text]
Chan, A. W., Quinn, M. J., Bhatt, D. L., Chew, D. P., Moliterno, D. J., Topol, E. J., Ellis, S. G.
(2002). Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. J Am Coll Cardiol
40: 669-675
[Abstract][Full Text]
Evans, J. G.
(2002). The gifts reserved for age. Int J Epidemiol
31: 792-795
[Full Text]
Gheorghiade, M., Goldstein, S.
(2002). {beta}-Blockers in the Post-Myocardial Infarction Patient. Circulation
106: 394-398
[Full Text]
Ko, D. T., Hebert, P. R., Coffey, C. S., Sedrakyan, A., Curtis, J. P., Krumholz, H. M.
(2002). {beta}-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction. JAMA
288: 351-357
[Abstract][Full Text]
Au, D. H., Curtis, J. R., Every, N. R., McDonell, M. B., Fihn, S. D.
(2002). Association Between Inhaled {beta}-Agonists and the Risk of Unstable Angina and Myocardial Infarction. Chest
121: 846-851
[Abstract][Full Text]
Wiklund, O., Hulthe, J., Wikstrand, J., Schmidt, C., Olofsson, S.-O., Bondjers, G.
(2002). Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study. Stroke
33: 572-577
[Abstract][Full Text]
Cleland, J. G F, John, J., Dhawan, J., Clark, A.
(2001). What is the optimal medical management of ischaemic heart failure?. Br Med Bull
59: 135-158
[Abstract][Full Text]
Giugliano, R.P, Llevadot, J, Wilcox, R.G, Gurfinkel, E.P, McCabe, C.H, Charlesworth, A, Thompson, S.L, Antman, E.M, Braunwald, E, for the In TIME II Investigators,
(2001). Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J
22: 1702-1715
[Abstract]
Zvara, D. A.
(2001). Treatment of Perioperative Myocardial Ischemia. SEMIN CARDIOTHORAC VASC ANESTH
5: 166-183
[Abstract]
Singh, B. N.
(2001). CIBIS, MERIT-HF, and COPERNICUS Trial Outcomes: Do They Complete the Chapter on -Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Drugs?. J CARDIOVASC PHARMACOL THER
6: 107-110
The IONA Study Group,
(2001). Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management. Heart
85: 9e-9
[Abstract][Full Text]
Chen, P.-S., Chen, L. S, Cao, J.-M., Sharifi, B., Karagueuzian, H. S, Fishbein, M. C
(2001). Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res
50: 409-416
[Abstract][Full Text]
Hedblad, B., Wikstrand, J., Janzon, L., Wedel, H., Berglund, G.
(2001). Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness : Main Results From the {beta}-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation
103: 1721-1726
[Abstract][Full Text]
Camm, A. J., Yap, Y. G.
(2001). Clinical Trials of Antiarrhythmic Drugs in Postmyocardial Infarction and Congestive Heart Failure Patients. J CARDIOVASC PHARMACOL THER
6: 99-106
Phillips, K. A., Shlipak, M. G., Coxson, P., Heidenreich, P. A., Hunink, M. G. M., Goldman, P. A., Williams, L. W., Weinstein, M. C., Goldman, L.
(2000). Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction. JAMA
284: 2748-2754
[Abstract][Full Text]
Lip, G.Y.H., Lydakis, C., Beevers, D.G.
(2000). Management of patients with myocardial infarction and hypertension. Eur Heart J
21: 1125-1134
Cao, J.-M., Chen, L. S., KenKnight, B. H., Ohara, T., Lee, M.-H., Tsai, J., Lai, W. W., Karagueuzian, H. S., Wolf, P. L., Fishbein, M. C., Chen, P.-S.
(2000). Nerve Sprouting and Sudden Cardiac Death. Circ. Res.
86: 816-821
[Abstract][Full Text]
Chen, J., Radford, M. J., Wang, Y., Marciniak, T. A., Krumholz, H. M.
(2000). Are {beta}-Blockers Effective in Elderly Patients Who Undergo Coronary Revascularization After Acute Myocardial Infarction?. Arch Intern Med
160: 947-952
[Abstract][Full Text]
Cohn, J. N., Ferrari, R., Sharpe, N., on Behalf of an International Forum on Cardiac Rem,
(2000). Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol
35: 569-582
[Abstract][Full Text]
AU, D. H., LEMAITRE, R. N., RANDALL CURTIS, J., SMITH, N. L., PSATY, B. M.
(2000). The Risk of Myocardial Infarction Associated with Inhaled beta -Adrenoceptor Agonists. Am. J. Respir. Crit. Care Med.
161: 827-830
[Abstract][Full Text]
Nuttall, S. L, Toescu, V., Kendall, M. J, Lipman, T.
(2000). beta Blockade after myocardial infarction. BMJ
320: 581-581
[Full Text]
Rosen, M. R.
(1999). Leaky Dikes and Fibrillating Swine. Circulation
100: 1942-1944
[Full Text]
Frohlich, E. D.
(1999). The necessity for recognition and treatment of patients with "mild" hypertension. J Am Coll Cardiol
34: 1369-1377
[Abstract][Full Text]
Rochon, P. A., Anderson, G. M., Tu, J. V., Clark, J. P., Gurwitz, J. H., Szalai, J. P., Lau, P.
(1999). Use of {beta}-blocker therapy in older patients after acute myocardial infarction in Ontario. CMAJ
161: 1403-1408
[Abstract][Full Text]
Kramer, C. M., Nicol, P. D., Rogers, W. J., Seibel, P. S., Park, C. S., Reichek, N.
(1999). beta -Blockade improves adjacent regional sympathetic innervation during postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol.
277: H1429-H1434
[Abstract][Full Text]
Soumerai, S. B., McLaughlin, T. J., Gurwitz, J. H., Pearson, S., Christiansen, C. L., Borbas, C., Morris, N., McLaughlin, B., Gao, X., Ross-Degnan, D.
(1999). Timeliness and Quality of Care for Elderly Patients With Acute Myocardial Infarction Under Health Maintenance Organization vs Fee-for-Service Insurance. Arch Intern Med
159: 2013-2020
[Abstract][Full Text]
Exner, D. V., Reiffel, J. A., Epstein, A. E., Ledingham, R., Reiter, M. J., Yao, Q., Duff, H. J., Follmann, D., Schron, E., Greene, H. L., Carlson, M. D., Brodsky, M. A., Akiyama, T., Baessler, C., Anderson, J. L., the AVID Investigators,
(1999). Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol
34: 325-333
[Abstract][Full Text]
Coodley, E.
(1999). Newer Drug Therapy for Congestive Heart Failure. Arch Intern Med
159: 1177-1183
[Abstract][Full Text]
McCormick, D., Gurwitz, J. H., Lessard, D., Yarzebski, J., Gore, J. M., Goldberg, R. J.
(1999). Use of Aspirin, {beta}-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial Infarction: Missed Opportunities for Prevention?. Arch Intern Med
159: 561-567
[Abstract][Full Text]
Spargias, K S, Hall, A S, Greenwood, D C, Ball, S G
(1999). beta Blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study. Heart
81: 25-32
[Abstract][Full Text]
Smith, N. L., Reiber, G. E., Psaty, B. M., Heckbert, S. R., Siscovick, D. S., Ritchie, J. L., Every, N. R., Koepsell, T. D.
(1998). Health outcomes associated with beta-blocker and diltiazem treatment of unstable angina. J Am Coll Cardiol
32: 1305-1311
[Abstract][Full Text]
Wang, T. J., Stafford, R. S.
(1998). National Patterns and Predictors of {beta}-Blocker Use in Patients With Coronary Artery Disease. Arch Intern Med
158: 1901-1906
[Abstract][Full Text]
Stevens, M. J., Raffel, D. M., Allman, K. C., Dayanikli, F., Ficaro, E., Sandford, T., Wieland, D. M., Pfeifer, M. A., Schwaiger, M.
(1998). Cardiac Sympathetic Dysinnervation in Diabetes : Implications for Enhanced Cardiovascular Risk. Circulation
98: 961-968
[Abstract][Full Text]
Gottlieb, S. S., McCarter, R. J., Vogel, R. A.
(1998). Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial Infarction. NEJM
339: 489-497
[Abstract][Full Text]
Njolstad, I., Arnesen, E.
(1998). Preinfarction Blood Pressure and Smoking Are Determinants for a Fatal Outcome of Myocardial Infarction: A Prospective Analysis From the Finnmark Study. Arch Intern Med
158: 1326-1332
[Abstract][Full Text]
Mehta, R. H, Eagle, K. A
(1998). Fortnightly review: Secondary prevention in acute myocardial infarction. BMJ
316: 838-842
[Full Text]
White, R. L
(1998). Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update. Asian Cardiovasc. Thorac. Ann.
6: 03-10
[Abstract][Full Text]
Collins, H. L., Dicarlo, S. E.
(1997). Daily exercise attenuates the sympathetic component of the arterial baroreflex control of heart rate. Am. J. Physiol. Heart Circ. Physiol.
273: H2613-H2619
[Abstract][Full Text]
Basu, S., Senior, R., Raval, U., van der Does, R., Bruckner, T., Lahiri, A.
(1997). Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction : A Placebo-Controlled, Randomized Trial. Circulation
96: 183-191
[Abstract][Full Text]
Domanski, M. J., Zipes, D. P., Schron, E.
(1997). Treatment of Sudden Cardiac Death : Current Understandings From Randomized Trials and Future Research Directions. Circulation
95: 2694-2699
[Full Text]
Clesham, G. J., Petch, M. C., Uretsky, B. F., Moss, A. J., Hall, W. J., The MADIT Investigators,
(1997). Implantable Defibrillators in Patients with Coronary Artery Disease at High Risk for Ventricular Arrhythmia. NEJM
336: 1676-1677
[Full Text]
Bostom, A. G., Bhargava, M., Sharma, A., de Tena, J. G., Hennekens, C. H., Albert, C. M., Buring, J. E.
(1997). Adjunctive Drug Therapy for Acute Myocardial Infarction. NEJM
336: 1455-1456
[Full Text]
DeQuattro, V., Li, D.
(1997). Antihypertensive Therapy in Patients Undergoing Noncardiac Surgery. J CARDIOVASC PHARMACOL THER
2: 331-335
[Abstract]
Hennekens, C. H., Albert, C. M., Godfried, S. L., Gaziano, J. M., Buring, J. E.
(1996). Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials. NEJM
335: 1660-1668
[Full Text]
Gleerup, G., Petersen, J. R., Mehlsen, J., Winther, K.
(1996). Effect of Spirapril and Hydrochlorothiazide on Platelet Function and Euglobulin Clot Lysis Time in Patients with Mild Hypertension. ANGIOLOGY
47: 951-956
[Abstract]
Sapsford, R. J, Robinson, M. B, Hall, A. S
(1996). Increasing prescription of drugs for secondary prevention of myocardial infarction. BMJ
312: 252a-252
[Full Text]
White, M., Wiechmann, R. J., Roden, R. L., Hagan, M. B., Wollmering, M. M., Port, J. D., Hammond, E., Abraham, W. T., Wolfel, E. E., Lindenfeld, J., Fullerton, D., Bristow, M. R.
(1995). Cardiac ß-Adrenergic Neuroeffector Systems in Acute Myocardial Dysfunction Related to Brain Injury : Evidence for Catecholamine-Mediated Myocardial Damage. Circulation
92: 2183-2189
[Abstract][Full Text]
Lamas, G. A., Flaker, G. C., Mitchell, G., Smith, S. C. Jr, Gersh, B. J., Wun, C.-C., Moye, L., Rouleau, J. L., Rutherford, J. D., Pfeffer, M. A., Braunwald, E., Investigators, f. t. S. V. E.
(1995). Effect of Infarct Artery Patency on Prognosis After Acute Myocardial Infarction. Circulation
92: 1101-1109
[Abstract][Full Text]
Hama, J., Nagata, S., Takenaka, T., Kino, H., Kamoi, K., Shimada, S., Horiuchi, M., Katori, R.
(1995). Atrial Natriuretic Peptide and Antihypertensive Action Due to {beta}-Blockade in Essential Hypertensive Patients. ANGIOLOGY
46: 511-516
[Abstract]
Armstrong, P. W., Furberg, C. D.
(1995). Clinical Trial Data and Safety Monitoring Boards : The Search for a Constitution. Circulation
91: 901-904
[Full Text]
Flapan, A D
(1994). Fortnightly Review: Management of patients after their first myocardial infarction. BMJ
309: 1129-1134
[Full Text]
Ayanian, J. Z., Hauptman, P. J., Guadagnoli, E., Antman, E. M, Pashos, C. L., McNeil, B. J.
(1994). Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug Therapy for Acute Myocardial Infarction. NEJM
331: 1136-1142
[Abstract][Full Text]
Roden, D. M.
(1994). Risks and Benefits of Antiarrhythmic Therapy. NEJM
331: 785-791
[Full Text]
Mason, J. W., The Electrophysiologic Study versus Electrocardiog,
(1993). A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias. NEJM
329: 452-458
[Abstract][Full Text]
Hueb, W., Bellotti, G., Sosa, E., Ramires, J. A., da Luz, P. L., Pileggi, F.
(1992). Ventricular Arrhythmias Induced by Programmed Ventricular Stimulation After Uncomplicated Myocardial Infarction. ANGIOLOGY
43: 578-584
[Abstract]
Elliot, E. C., Kollarits, C. R.
(1992). Expansion of Contracted Visual Fields Following Treatment with Pentoxifylline in Two Patients with Coexistent Peripheral Vascular Disease Case Reports. ANGIOLOGY
43: 362-367
[Abstract]
Straka, R. J., Marshall, P. S.
(1992). The Clinical Significance of the Pharmacogenetics of Cardiovascular Medications. Journal of Pharmacy Practice
5: 337-361
[Abstract]
Pistevos, A., Georgiou, J., Darsinos, I.
(1989). Progress of Coronary Artery Disease: Compliance to Therapy. ANGIOLOGY
40: 666-670
[Abstract]
(1989). Cardiogenic Brain Embolism: The Second Report of the Cerebral Embolism Task Force. Arch Neurol
46: 727-743
[Abstract]
Johansson, B. W., Hansen, O., Juul-Moller, S., Svensson, O.
(1988). Adrenaline-Induced Changes in Serum Electrolytes, ECG, and Blood Pressure, with Ca-Blockade Pretreatment. ANGIOLOGY
39: 345-354
[Abstract]
Midtbo, K., Silke, B., Verma, S.P., Reynolds, G.W., Hafizullah, M., Taylor, S.H.
(1988). Circulatory Effects of Intravenous and Oral Atenolol in Acute Myocardial Infarction. ANGIOLOGY
39: 795-801
[Abstract]
Hirsh, J., Cairns, J. A.
(1987). Analytic Reviews : Antithrombotic Tberapy in Acute Myocardial Infarction and Unstable Angina. J Intensive Care Med
2: 299-312
Imperial, E. S
(1987). Approach to cardiac rehabilitation. Clin Rehabil
1: 203-210
[Abstract]
Levy, R., Moskowitz, J
(1982). Cardiovascular research: decades of progress, a decade of promise. Science
217: 121-129
[Abstract]
